Clinical trials
Phase 2 Muscular Dystrophy, Facioscapulohumeral trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
8 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2016 | 1 |
| 2019 | 2 |
| 2020 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 3 |
| Completed | 2 |
| Active, not recruiting | 1 |
| Not yet recruiting | 1 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA | 2 |
| Fulcrum Therapeutics | 2 |
| Avidity Biosciences, Inc. | 1 |
| Hoffmann-La Roche | 1 |
| Satellos Bioscience, Inc. | 1 |
| Scholar Rock, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Muscular Dystrophy, Facioscapulohumeral | 8 |
| Muscular Dystrophies | 3 |
| Musculoskeletal Diseases | 2 |
| Neuromuscular Diseases | 2 |
| Charcot-Marie-Tooth Disease | 1 |
Trials
Showing 26 to 8 of 8. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.